138 related articles for article (PubMed ID: 7735620)
21. Preliminary report: the origin of lavage neutrophils in fibrosing alveolitis associated with systemic sclerosis.
Reich JM
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Sep; 14(2):189-90. PubMed ID: 9306513
[No Abstract] [Full Text] [Related]
22. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung.
Hancock A; Armstrong L; Gama R; Millar A
Am J Respir Cell Mol Biol; 1998 Jan; 18(1):60-5. PubMed ID: 9448046
[TBL] [Abstract][Full Text] [Related]
23. Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8.
Lynch JP; Standiford TJ; Rolfe MW; Kunkel SL; Strieter RM
Am Rev Respir Dis; 1992 Jun; 145(6):1433-9. PubMed ID: 1596015
[TBL] [Abstract][Full Text] [Related]
24. Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis.
Bolster MB; Ludwicka A; Sutherland SE; Strange C; Silver RM
Arthritis Rheum; 1997 Apr; 40(4):743-51. PubMed ID: 9125259
[TBL] [Abstract][Full Text] [Related]
25. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
[TBL] [Abstract][Full Text] [Related]
26. Immunoregulatory proteins in bronchoalveolar lavage fluid. A comparative analysis of pigeon breeders' disease, sarcoidosis and idiopathic pulmonary fibrosis.
Reynolds SP; Jones KP; Edwards JH; Davies BH
Sarcoidosis; 1989 Sep; 6(2):125-34. PubMed ID: 2602684
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of IL-8 secretion by alveolar macrophages from patients with fibrosing alveolitis: a subpopulation analysis.
Pantelidis P; Southcott AM; Black CM; Du Bois RM
Clin Exp Immunol; 1997 Apr; 108(1):95-104. PubMed ID: 9097917
[TBL] [Abstract][Full Text] [Related]
28. Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.
Sahhar J; Littlejohn G; Conron M
Intern Med J; 2004 Nov; 34(11):626-38. PubMed ID: 15546457
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement.
Crestani B; Seta N; De Bandt M; Soler P; Rolland C; Dehoux M; Boutten A; Dombret MC; Palazzo E; Kahn MF
Am J Respir Crit Care Med; 1994 May; 149(5):1260-5. PubMed ID: 8173768
[TBL] [Abstract][Full Text] [Related]
30. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
31. Subclinical pulmonary involvement assessed by bronchoalveolar lavage in patients with early undifferentiated connective tissue disease.
Kumánovics G; Zibotics H; Juhász E; Komócsi A; Czirják L
Clin Exp Rheumatol; 2001; 19(5):551-9. PubMed ID: 11579714
[TBL] [Abstract][Full Text] [Related]
32. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium.
Wells AU; Lorimer S; Majumdar S; Harrison NK; Corrin B; Black CM; Jeffery PK; du Bois RM
Eur Respir J; 1995 Feb; 8(2):266-71. PubMed ID: 7758562
[TBL] [Abstract][Full Text] [Related]
33. PET scanning of macrophages in patients with scleroderma fibrosing alveolitis.
Branley HM; du Bois RM; Wells AU; Jones HA
Nucl Med Biol; 2008 Nov; 35(8):901-9. PubMed ID: 19026952
[TBL] [Abstract][Full Text] [Related]
34. Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography.
Wells AU; Hansell DM; Rubens MB; King AD; Cramer D; Black CM; du Bois RM
Arthritis Rheum; 1997 Jul; 40(7):1229-36. PubMed ID: 9214422
[TBL] [Abstract][Full Text] [Related]
35. In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases.
Prior C; Haslam PL
Clin Exp Immunol; 1992 May; 88(2):280-7. PubMed ID: 1572093
[TBL] [Abstract][Full Text] [Related]
36. Bronchoalveolar lavage fluid (BALF) analysis in interstitial lung diseases--a 7-year experience.
Sharma SK; Pande JN; Verma K; Guleria JS
Indian J Chest Dis Allied Sci; 1989; 31(3):187-96. PubMed ID: 2638654
[TBL] [Abstract][Full Text] [Related]
37. Mast cells' contribution to the fibrosing alveolitis of the scleroderma lung.
Chanez P; Lacoste JY; Guillot B; Giron J; Barnéon G; Enander I; Godard P; Michel FB; Bousquet J
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1497-502. PubMed ID: 8503561
[TBL] [Abstract][Full Text] [Related]
38. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
[TBL] [Abstract][Full Text] [Related]
39. Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis.
Haslam PL; Cromwell O; Dewar A; Turner-Warwick M
Clin Exp Immunol; 1981 Jun; 44(3):587-93. PubMed ID: 7326869
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. A potential mechanism for the recruitment and activation of neutrophils in lung fibrosis.
Carré PC; Mortenson RL; King TE; Noble PW; Sable CL; Riches DW
J Clin Invest; 1991 Dec; 88(6):1802-10. PubMed ID: 1752942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
